Apple R&D increased by 4.9% to $11.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.6%, from $8.55B to $11.42B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 12.1% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.72B | $5.77B | $6.31B | $6.39B | $6.80B | $6.76B | $7.71B | $7.46B | $7.44B | $7.31B | $7.70B | $7.90B | $8.01B | $7.77B | $8.27B | $8.55B | $8.87B | $8.87B | $10.89B | $11.42B |
| QoQ Change | — | +1.0% | +9.3% | +1.3% | +6.4% | -0.5% | +14.0% | -3.3% | -0.2% | -1.8% | +5.3% | +2.7% | +1.3% | -3.0% | +6.5% | +3.4% | +3.7% | +0.0% | +22.8% | +4.9% |
| YoY Change | — | — | — | — | +18.9% | +17.1% | +22.2% | +16.8% | +9.5% | +8.1% | -0.2% | +6.0% | +7.6% | +6.3% | +7.4% | +8.2% | +10.7% | +14.2% | +31.7% | +33.6% |